IMA早期诊断结合介入治疗在UAP中的临床应用研究(5)
第1页 |
参见附件。
[16]Paul O Collinson,David C Gaze.Biomarkers of cardiovascular damage and dysfunction-an overview[J].Heart Lung Circ,2007,16(3):71-82.
[17]Roy D,Quiles J,Aldama G,et al. Ischem ia modified albumin for the assessment of patients p resenting to the emergency department with acute chest pain but non-diagno stic 12-lead electrocardiograms and negative cardiac troponin T[J].Int J Cardiol,2004,97(2): 297-301.
[18]Quiles J,Roy D,Gaze D,et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia[J]. American Journal of Cardiology,2003,92(3):322-324.
[19]Garrido IP,Roy D,Calvino R,et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals[J].Am J Cardiol,2004,93(1):88-90.
[20]Cho DK,Choi JO,Kim SH,et al. Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm[J].Coron Artery Dis,2007,18(2):83-87.
[21]Sinha MK,Gaze DC, Tippins JR,et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention[J]. Circulation,2003,107(19):2403-2405.
[22]Bar-Or D,Winkler JV,Vanbenthuysen K, et al. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous trans luminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin[J].Am Heart J,2001,141(6):985-991.
[23]陈建军,李向平.急性冠脉综合征血清缺血修饰白蛋白的动态变化[J].中国循环杂志,2007,22(1):13-16.
您现在查看是摘要介绍页,详见PDF附件。